Randomized phase iii study of gemcitabine plus S-1, S-1 alone, or gemcitabine alone in patients with locally advanced and metastatic pancreatic cancer in Japan and Taiwan: Gest study

Hideki Ueno, Tatsuya Ioka, Masafumi Ikeda, Shinichi Ohkawa, Hiroaki Yanagimoto, Narikazu Boku, Akira Fukutomi, Kazuya Sugimori, Hideo Baba, Kenji Yamao, Tomotaka Shimamura, Masayuki Sho, Masayuki Kitano, Ann Lii Cheng, Kazuhiro Mizumoto, Jen Shi Chen, Junji Furuse, Akihiro Funakoshi, Takashi Hatori, Taketo YamaguchiShinichi Egawa, Atsushi Sato, Yasuo Ohashi, Takuji Okusaka, Masao Tanaka

Research output: Contribution to journalArticlepeer-review

392 Citations (Scopus)

Fingerprint Dive into the research topics of 'Randomized phase iii study of gemcitabine plus S-1, S-1 alone, or gemcitabine alone in patients with locally advanced and metastatic pancreatic cancer in Japan and Taiwan: Gest study'. Together they form a unique fingerprint.

Medicine & Life Sciences